TY  - CONF

T1  - Progressive and sustained Disease Control in Patients with atopic Dermatitis (AD) aged 12 to 17 Years treated with Tralokinumab for 52 Weeks

JO  - ALLERGOLOGIE

PY  - 2024/01/01

AU  - Wollenberg A

AU  - Cork M

AU  - Chih-ho-Hong H

AU  - Kurbasic A

AU  - Vacko E

AU  - Paller AS

ED  - 

VL  - 47

IS  - 9

Y2  - 2024/12/22

ER  -